Results
1 -
8 of
8
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 3 Natural Compounds and Synthetic Drugs to Target Type-1 Cannabinoid (CB1) Receptor. Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis
, 2021
, Pages 48-88
- Anti-Inflammatory Drug Discovery, CHAPTER 13 Recent Advances in Selective CB2 Agonists for the Treatment of Pain. E. J. GILBERT, C. A. LUNN
, 2012
, Pages 391-413
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 4 Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2) Receptor. Wolfgang Guba, Marc Nazaré, Uwe Grether
, 2021
, Pages 89-167
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 2 Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System. Javier Fernández-Ruiz, Onintza Sagredo, Eva de Lago
, 2021
, Pages 10-47
- Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging. David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
- Forensic Analytical Methods, CHAPTER 9 Paper Spray Ionization Mass Spectrometry in Forensic Chemistry. João Francisco Allochio Filho, Clebson de Jesus Macrino, Valdemar Lacerda, Marcella Ferreira Rodrigues, Boniek G. Vaz, Wanderson Romão
, 2019
, Pages 198-243
- Mass Spectrometry: Volume 10, The use of mass spectrometry in studies of drug metabolism and pharmacokinetics. M. E. Rose, D. J. Harvey
, 1989
, Volume 10
, Pages 273-322
- Nuclear Magnetic Resonance: Volume 27, Conformational analysis. G. A. Webb, J. R. P. Arnold, J. Fisher
, 1998
, Volume 27
, Pages 370-385